Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interaction of Glucagon and Insulin on EGP
NCT04461015Phase 3Completed
- Start
- Oct 2020
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms). Primary endpoint: Endogenous Glucose Production. Started Oct 2020; status: completed.
Beyond the preview
Go deeper on NCT04461015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04461015.